Results from first clinical study evaluating KB-195 in patients with urea cycle disorders Sep. 16, 2019
Noxxon initiates phase I/II trial of NOX-A12 with radiotherapy for newly diagnosed brain cancer Sep. 13, 2019
Phase III study of CC-486 as maintenance therapy in AML meets primary and key secondary endpoints Sep. 13, 2019
ADC Therapeutics studies ADCT-301 for relapsed or refractory Hodgkin's lymphoma in phase II Sep. 13, 2019
RSS